{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:13:35Z","timestamp":1791274415365,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.gde.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T15:16:18Z","timestamp":1299510978000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Genetics of Alzheimer's disease: new evidences for an old hypothesis?"],"prefix":"10.1016","volume":"21","author":[{"given":"Jean-Charles","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2011.02.002_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.gde.2011.02.002_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","article-title":"Amyloid, the presenilins and Alzheimer's disease","volume":"20","author":"Hardy","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.gde.2011.02.002_bib0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2011.02.002_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0025","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0030","doi-asserted-by":"crossref","first-page":"1891S","DOI":"10.1093\/jn\/127.9.1891S","article-title":"The genetics of human noninsulin-dependent (type 2) diabetes mellitus","volume":"127","author":"Elbein","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/j.gde.2011.02.002_bib0035","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson's disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0040","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.psyneuen.2007.05.015","article-title":"Genetic heterogeneity of Alzheimer's disease: complexity and advances","volume":"32","author":"Lambert","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.gde.2011.02.002_bib0045","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.gde.2011.02.002_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2007.3","article-title":"Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease","volume":"65","author":"Li","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2011.02.002_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1755-8794-1-44","article-title":"A genome-wide association study for late-onset Alzheimer's disease using DNA pooling","volume":"1","author":"Abraham","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.gde.2011.02.002_bib0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng.305","article-title":"Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease","volume":"41","author":"Carrasquillo","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","article-title":"Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease","volume":"84","author":"Beecham","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0085_1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0090_1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0095_1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.gde.2011.02.002_bib0100_1","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","article-title":"Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals","volume":"19","author":"Corneveaux","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0105","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archneurol.2010.147","article-title":"Replication of CLU, CR1, and PICALM associations with Alzheimer disease","volume":"67","author":"Carrasquillo","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0290","first-page":"1473","article-title":"Meta-analysis Confirms CR1","volume":"67","author":"Jun","year":"2010","journal-title":"CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Arch Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0295_1","first-page":"207","article-title":"The role of CLU","volume":"68","author":"Schjeide","year":"2011","journal-title":"CR1, and PICALM on Alzheimer's disease risk and CSF biomarker levels. Arch Gen Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cca.2010.06.013","article-title":"Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease","volume":"411","author":"Yu","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.gde.2011.02.002_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2010.06.018","article-title":"Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease","volume":"1348","author":"Zhang","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.gde.2011.02.002_bib0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/mp.2008.141","article-title":"Examination of the current top candidate genes for AD in a genome-wide association study","volume":"15","author":"Feulner","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3233\/JAD-2010-100126","article-title":"Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study","volume":"20","author":"Laumet","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.gde.2011.02.002_bib0140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/498851","article-title":"A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease","volume":"78","author":"Grupe","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2011.02.002_bib0155_1","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2011.02.002_bib0160_1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2011.02.002_bib0165","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/jnnp.2004.048983","article-title":"Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?","volume":"76","author":"Lambert","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(97)01543-3","article-title":"Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene","volume":"421","author":"Artiga","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.gde.2011.02.002_bib0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmg.2003.005033","article-title":"The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease","volume":"41","author":"Lambert","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.gde.2011.02.002_bib0180","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(00)04063-0","article-title":"Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease","volume":"357","author":"Lambert","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gde.2011.02.002_bib0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.59.1.59","article-title":"Contribution of APOE promoter polymorphisms to Alzheimer's disease risk","volume":"59","author":"Lambert","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2011.02.002_bib0190","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","article-title":"Apolipoproteins in human cerebrospinal fluid","volume":"76","author":"Roheim","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2011.02.002_bib0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0166-2236(92)90190-J","article-title":"Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration","volume":"15","author":"May","year":"1992","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.gde.2011.02.002_bib0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2011.02.002_bib0205","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2011.02.002_bib0210","first-page":"1247","article-title":"Differential expression of individual complement regulators in the brain and choroid plexus","volume":"79","author":"Singhrao","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.gde.2011.02.002_bib0215","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.gde.2011.02.002_bib0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/bies.20193","article-title":"The choroid plexus in the rise, fall and repair of the brain","volume":"27","author":"Emerich","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.gde.2011.02.002_bib0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.04.035","article-title":"Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study","volume":"199","author":"Vercellino","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.gde.2011.02.002_bib0230_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","article-title":"Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis","volume":"20","author":"Lambert","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.gde.2011.02.002_bib0235","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neurobiolaging.2004.06.008","article-title":"Human monoclonal antibodies against amyloid-beta from healthy adults","volume":"26","author":"Geylis","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.gde.2011.02.002_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.21475","article-title":"Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden","volume":"65","author":"Kellner","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0245","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1091\/mbc.10.8.2687","article-title":"Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic","volume":"10","author":"Tebar","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.gde.2011.02.002_bib0250","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1074\/jbc.272.24.15101","article-title":"A new member of the amphiphysin family connecting endocytosis and signal transduction pathways","volume":"272","author":"Leprince","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2011.02.002_bib0255_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","article-title":"Distribution and expression of picalm in Alzheimer disease","volume":"69","author":"Baig","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.gde.2011.02.002_bib0260","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.gde.2011.02.002_bib0265","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2011.02.002_bib0270","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1161\/STROKEAHA.110.598326","article-title":"Where vascular meets neurodegenerative disease","volume":"41","author":"Schneider","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.gde.2011.02.002_bib0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.mp.4002089","article-title":"Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease","volume":"14","author":"Bensemain","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0280","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mp.2009.10","article-title":"Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease","volume":"14","author":"Chapuis","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.gde.2011.02.002_bib0285_1","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS {beta}-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X11000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X11000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:39:33Z","timestamp":1760701173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X11000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0959437X11000451"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2011.02.002","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Alzheimer's disease: new evidences for an old hypothesis?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2011.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}